SGX announced today that they will be working with Third500 to build an IPO market in Singapore for emerging growth companies. Third500 is the Singapore-based unit of one of our origination partners, US-based Healthios Capital Markets.
Healthios and Third500 operate on a traditional investment banking model, originating deals in their home country and bringing it to syndication partners like us and listing partners like SGX. CapBridge syndicates deals brought from the US from Healthios through our extensive Asia investor base. These deals are syndicated from intermediaries, as well as deals directly from companies who look to CapBridge as an intelligent and optimised capital-raising option.
Our goal is to provide an extensive breadth of opportunities to a wide stable of investors, catering to varied investment mandates and styles. We will continue to focus on our key strengths of capital raising, anchored by our technology platform that engages our wide base of investors, especially in Asia.
Capbridge understands deeply and is well-connected to our various investor base here via our platform; we strategically facilitate the investment matching process working alongside various parties and intermediaries, leveraging on our digital platform and broad base reach and partnerships.
Some of the deals brought to CapBridge, which we have successfully syndicated to our Asia investor base including data centre startup Nautilus Data Technologies Inc’s Series C preferred stock funding, and clinical biopharmaceutical company Liquidia Technologies (recently listed on NASDAQ). We are concurrently working on several other deals that you can check out here.
Once again, congratulations to our origination partner Healthios and Third500. We look forward to working together as we continue to offer quality investment opportunities to our extensive network of Asia investors.